Regarding ovarian germ cell tumors, all of the following statements are correct EXCEPT:

Explanation

## Analysis of Ovarian Germ Cell Tumor Characteristics ### Identifying the EXCEPT Answer In "all EXCEPT" questions, we must find the **false** statement among the options. --- ### Option A: Dysgerminoma — CORRECT STATEMENT ✓ - Dysgerminoma is the **most common malignant ovarian germ cell tumor** (~40–50% of malignant GCTs) - It is **highly radiosensitive** (analogous to testicular seminoma in males) - Bilateral in ~10–15% of cases - Excellent prognosis with modern therapy (surgery ± BEP chemotherapy) --- ### Option B: Yolk Sac Tumor — CORRECT STATEMENT ✓ - Also called endodermal sinus tumor - Characteristically produces **alpha-fetoprotein (AFP)** — the key tumor marker - Pathognomonic **Schiller-Duval bodies**: papillary structures with a central blood vessel surrounded by tumor cells, resembling glomeruli - Most common malignant GCT in children; highly aggressive but chemosensitive --- ### Option C: Immature Teratoma — INCORRECT STATEMENT ✗ (THE ANSWER) - Immature teratoma IS graded I–III based on the **amount of immature neuroepithelial tissue** — this part is correct - However, the claim that immature teratoma has a **"better prognosis than mature cystic teratoma"** is **FALSE** - Mature cystic teratoma (dermoid cyst) is **benign** with an excellent prognosis after surgical excision - Immature teratoma is **malignant**; even Grade I carries malignant potential and requires chemotherapy in many cases - Comparing a malignant tumor favorably to a benign one is factually incorrect — immature teratoma has a **worse** prognosis than mature cystic teratoma - *Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed., Chapter on Female Genital Tract* --- ### Option D: Choriocarcinoma — CORRECT STATEMENT (partially) ✓ - Ovarian choriocarcinoma does produce **hCG** — correct - The statement says it "typically arises from gestational trophoblastic disease" — while this phrasing is imprecise (primary ovarian choriocarcinoma is a germ cell tumor, not GTD-derived), the option is testing hCG production, which is accurate - This option is less clearly false than Option C --- ### Summary Table | Tumor | Key Marker | Pathognomonic Feature | Prognosis | |---|---|---|---| | Dysgerminoma | LDH, β-hCG (mild) | Fibrous septa with lymphocytes | Good (radiosensitive) | | Yolk Sac Tumor | AFP | Schiller-Duval bodies | Aggressive; chemo-responsive | | Immature Teratoma | AFP (variable) | Immature neuroepithelium | **Malignant** — worse than mature teratoma | | Mature Cystic Teratoma | None | Ectodermal derivatives | **Benign** — excellent prognosis | **High-Yield:** Immature teratoma is graded I–III by the amount of immature neuroepithelium per low-power field (Norris grading system). It is malignant and has a **worse** prognosis than mature cystic teratoma, which is benign. **Key Point:** The false statement in Option C is the comparison of prognosis — a malignant tumor (immature teratoma) cannot have a "better prognosis" than a benign tumor (mature cystic teratoma). This is a classic NEET PG trap. **Clinical Pearl:** AFP elevation in a young woman with an ovarian mass suggests yolk sac tumor or immature teratoma; hCG elevation suggests choriocarcinoma or dysgerminoma (with syncytiotrophoblastic giant cells).